Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Gross Profit (2016 - 2025)

Historic Gross Profit for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $418000.0.

  • Arcadia Biosciences' Gross Profit fell 1722.77% to $418000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 1469.69%. This contributed to the annual value of $2.1 million for FY2024, which is 868.42% down from last year.
  • Per Arcadia Biosciences' latest filing, its Gross Profit stood at $418000.0 for Q3 2025, which was down 1722.77% from $631000.0 recorded in Q2 2025.
  • Arcadia Biosciences' 5-year Gross Profit high stood at $673000.0 for Q2 2024, and its period low was -$6.7 million during Q4 2022.
  • For the 5-year period, Arcadia Biosciences' Gross Profit averaged around $1263.2, with its median value being $480000.0 (2023).
  • Examining YoY changes over the last 5 years, Arcadia Biosciences' Gross Profit showed a top increase of 42740.74% in 2022 and a maximum decrease of 132930.4% in 2022.
  • Arcadia Biosciences' Gross Profit (Quarter) stood at $546000.0 in 2021, then tumbled by 1329.3% to -$6.7 million in 2022, then skyrocketed by 108.92% to $599000.0 in 2023, then crashed by 35.06% to $389000.0 in 2024, then increased by 7.46% to $418000.0 in 2025.
  • Its Gross Profit was $418000.0 in Q3 2025, compared to $631000.0 in Q2 2025 and $518000.0 in Q1 2025.